Pediatrix confirms stable payor mix and reaffirms 2026 Adjusted EBITDA outlook
The company reported stable payor mix metrics and reaffirmed its FY2026 adjusted EBITDA forecast of $280M to $300M. Management stated it remains on track despite sector-wide reports and will host an earnings call on August 4.
View filing at SEC.gov →